124 related articles for article (PubMed ID: 2864375)
1. Mouse skin graft prolongation with donor strain bone marrow and anti-lymphocyte serum: surface markers of the active bone marrow cells.
De Fazio S; Hartner WC; Monaco AP; Gozzo JJ
J Immunol; 1985 Nov; 135(5):3034-8. PubMed ID: 2864375
[TBL] [Abstract][Full Text] [Related]
2. Characterization of spleen cells capable of inducing unresponsiveness in ALS-treated mice.
Wood ML; Monaco AP; Gottschalk R
Transplantation; 1991 Jan; 51(1):208-13. PubMed ID: 1670969
[TBL] [Abstract][Full Text] [Related]
3. Murine lymphokine-activated killer (LAK) cells: phenotypic characterization of the precursor and effector cells.
Yang JC; Mulé JJ; Rosenberg SA
J Immunol; 1986 Jul; 137(2):715-22. PubMed ID: 2873187
[TBL] [Abstract][Full Text] [Related]
4. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
Thierfelder S; Cobbold S; Kummer U; Waldmann H; Schuh R
Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278
[TBL] [Abstract][Full Text] [Related]
5. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
[TBL] [Abstract][Full Text] [Related]
6. Human antibody-dependent cellular cytotoxicity. Isolation and identification of a subpopulation of peripheral blood lymphocytes which kill antibody-coated autologous target cells.
Brier AM; Chess L; Schlossman SF
J Clin Invest; 1975 Dec; 56(6):1580-6. PubMed ID: 53242
[TBL] [Abstract][Full Text] [Related]
7. The effect of cyclophosphamide on the splecific unresponsiveness to skin allografts induced in ALS-treated mice infused with donor bone marrow.
Wood ML; Monaco AP
J Immunol; 1977 Apr; 118(4):1456-9. PubMed ID: 321691
[TBL] [Abstract][Full Text] [Related]
8. Natural cytotoxicity against mouse hepatitis virus-infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype.
Welsh RM; Haspel MV; Parker DC; Holmes KV
J Immunol; 1986 Feb; 136(4):1454-60. PubMed ID: 3003199
[TBL] [Abstract][Full Text] [Related]
9. Antibody-dependent cellular cytotoxicity effector cells lack Ia antigens.
Nelson DL; Sachs DH; Dickler HB
J Immunol; 1977 Sep; 119(3):1034-40. PubMed ID: 330744
[TBL] [Abstract][Full Text] [Related]
10. Prolongation of allograft survival in mice by administration of anti-Thy 1 serum. I. Mediation by in vivo activation of regulatory T cells.
Gelfand MC; Paul WE
J Immunol; 1975 Jul; 115(1):1-4. PubMed ID: 1097498
[TBL] [Abstract][Full Text] [Related]
11. Thy-1+ epidermal cells proliferate in response to concanavalin A and interleukin 2.
Nixon-Fulton JL; Bergstresser PR; Tigelaar RE
J Immunol; 1986 Apr; 136(8):2776-86. PubMed ID: 2870120
[TBL] [Abstract][Full Text] [Related]
12. [Comparative studies of Fc receptors for IgG on resting and activated mouse T lymphocytes using different methods].
Hückel C; Sandor M; Erdei A; Jensen HL; Brock J; Rychly J; Gergely J
Allerg Immunol (Leipz); 1986; 32(1):47-56. PubMed ID: 2940850
[TBL] [Abstract][Full Text] [Related]
13. Anti-Thy-1 plus complement-treated, cultured bone marrow cells resemble fetal thymocytes in killer cell function and marker expression.
Hurwitz JL; McAndrew EC; Doherty PC
J Immunol; 1986 Sep; 137(6):1757-63. PubMed ID: 2875109
[TBL] [Abstract][Full Text] [Related]
14. Isolation by continuous density gradient centrifugation and characterization of bone marrow cells active in prolonging allograft survival in antilymphocyte serum (ALS)-treated mice.
De Fazio SR; Kowolenko M; Monaco AP; Gozzo JJ
Transplant Proc; 1987 Feb; 19(1 Pt 1):547-8. PubMed ID: 2856297
[No Abstract] [Full Text] [Related]
15. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent strain spleen cells. I. Induction of a nylon-adherent, Thy-1+Lyt-1+2- suppressor cell.
Kosmatopoulos K; Orbach-Arbouys S
J Immunol; 1987 Feb; 138(3):704-12. PubMed ID: 2879865
[TBL] [Abstract][Full Text] [Related]
16. Ly-4.2: a cell membrane alloantigen of murine B lymphocytes. I. Population studies.
McKenzie IF; Snell GD
J Immunol; 1975 Feb; 114(2 pt 2):848-55. PubMed ID: 1078681
[TBL] [Abstract][Full Text] [Related]
17. Prolongation of graft survival in ALS-treated mice by donor-specific bone marrow. Density gradient fractionation of the active bone marrow cells.
De Fazio SR; Hartner WC; Monaco AP; Gozzo JJ
Transplantation; 1987 Apr; 43(4):564-70. PubMed ID: 2953092
[TBL] [Abstract][Full Text] [Related]
18. Control of Fc and C3 receptors on myeloid leukemic cells.
Lotem J; Sachs L
J Immunol; 1976 Aug; 117(2):580-6. PubMed ID: 950462
[TBL] [Abstract][Full Text] [Related]
19. Effect of granulocyte-macrophage colony-stimulating factor on the induction of unresponsiveness by lymphoid cells.
Monaco AP; Wood ML; Gottschalk R; Seiler FR
Transplantation; 1991 Jan; 51(1):213-8. PubMed ID: 1670970
[TBL] [Abstract][Full Text] [Related]
20. "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell.
Kiessling R; Klein E; Pross H; Wigzell H
Eur J Immunol; 1975 Feb; 5(2):117-21. PubMed ID: 1086218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
